Cargando…

Inhibition of lysophosphatidic acid receptors 1 and 3 attenuates atherosclerosis development in LDL-receptor deficient mice

Lysophosphatidic acid (LPA) is a natural lysophospholipid present at high concentrations within lipid-rich atherosclerotic plaques. Upon local accumulation in the damaged vessels, LPA can act as a potent activator for various types of immune cells through its specific membrane receptors LPA(1/3.) LP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kritikou, Eva, van Puijvelde, Gijs H. M., van der Heijden, Thomas, van Santbrink, Peter J., Swart, Maarten, Schaftenaar, Frank H., Kröner, Mara J., Kuiper, Johan, Bot, Ilze
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121611/ https://www.ncbi.nlm.nih.gov/pubmed/27883026 http://dx.doi.org/10.1038/srep37585

Ejemplares similares

Defective Autophagy in T Cells Impairs the Development of Diet-Induced Hepatic Steatosis and Atherosclerosis
por: Amersfoort, Jacob, et al.
Publicado: (2018)

Induction of HLA-A2 restricted CD8 T cell responses against ApoB100 peptides does not affect atherosclerosis in a humanized mouse model
por: Schaftenaar, Frank H., et al.
Publicado: (2019)

IFNγ-Stimulated B Cells Inhibit T Follicular Helper Cells and Protect Against Atherosclerosis
por: Douna, Hidde, et al.
Publicado: (2022)

Agonistic Anti-TIGIT Treatment Inhibits T Cell Responses in LDLr Deficient Mice without Affecting Atherosclerotic Lesion Development
por: Foks, Amanda C., et al.
Publicado: (2013)

CD1d deficiency inhibits the development of abdominal aortic aneurysms in LDL receptor deficient mice
por: van Puijvelde, Gijs H. M., et al.
Publicado: (2018)

Diet-induced dyslipidemia induces metabolic and migratory adaptations in regulatory T cells
por: Amersfoort, Jacob, et al.
Publicado: (2020)

Mesenchymal Stem Cells Reduce Murine Atherosclerosis Development
por: Frodermann, Vanessa, et al.
Publicado: (2015)

Hematopoietic Sphingosine 1-Phosphate Lyase Deficiency Decreases Atherosclerotic Lesion Development in LDL-Receptor Deficient Mice
por: Bot, Martine, et al.
Publicado: (2013)

Recycling the LDL receptor to combat atherosclerosis
por: Vos, Dyonne, et al.
Publicado: (2018)

Leukocyte TLR5 deficiency inhibits atherosclerosis by reduced macrophage recruitment and defective T-cell responsiveness
por: Ellenbroek, Guilielmus H.J.M., et al.
Publicado: (2017)

A novel CCR2 antagonist inhibits atherogenesis in apoE deficient mice by achieving high receptor occupancy
por: Bot, Ilze, et al.
Publicado: (2017)

Antisense Oligonucleotide Inhibition of MicroRNA-494 Halts Atherosclerotic Plaque Progression and Promotes Plaque Stabilization
por: van Ingen, Eva, et al.
Publicado: (2019)

Local Mast Cell Activation Promotes Neovascularization
por: Bot, Ilze, et al.
Publicado: (2020)

Flow Cytometry-Based Characterization of Mast Cells in Human Atherosclerosis
por: Kritikou, Eva, et al.
Publicado: (2019)

Cannabinoid Receptor 2 Deficiency in Haematopoietic cells Aggravates Early Atherosclerosis in LDL Receptor Deficient Mice
por: Delsing, Dianne J.M, et al.
Publicado: (2011)

Leukocyte ABCA1 Remains Atheroprotective in Splenectomized LDL Receptor Knockout Mice
por: Lammers, Bart, et al.
Publicado: (2012)

Fluorescent small-molecule agonists as follicle-stimulating hormone receptor imaging tools
por: Hoogendoorn, Sascha, et al.
Publicado: (2020)

Amygdalin ameliorates the progression of atherosclerosis in LDL receptor-deficient mice
por: Lv, Jianzhen, et al.
Publicado: (2017)

Stress-induced mast cell activation contributes to atherosclerotic plaque destabilization
por: Lagraauw, H. Maxime, et al.
Publicado: (2019)

Hyperhomocysteinemia independently causes and promotes atherosclerosis in LDL receptor-deficient mice
por: Guo, Hang-Yuan, et al.
Publicado: (2014)

Pregnane X Receptor Mediates Atherosclerosis Induced by Dicyclohexyl Phthalate in LDL Receptor-Deficient Mice
por: Liu, Jingwei, et al.
Publicado: (2022)

Elevated plasma levels of lysophosphatidic acid and aberrant expression of lysophosphatidic acid receptors in adenomyosis
por: Yang, Bicheng, et al.
Publicado: (2017)

Tc17 CD8(+) T cells accumulate in murine atherosclerotic lesions, but do not contribute to early atherosclerosis development
por: van Duijn, Janine, et al.
Publicado: (2020)

Blockade of the BLT1-LTB(4) axis does not affect mast cell migration towards advanced atherosclerotic lesions in LDLr(−/−) mice
por: Depuydt, Marie A. C., et al.
Publicado: (2022)

Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis
por: de Jager, Saskia C.A., et al.
Publicado: (2011)

2-Carba-lysophosphatidic acid is a novel β-lysophosphatidic acid analogue with high potential for lysophosphatidic acid receptor activation and autotaxin inhibition
por: Fukasawa, Keiko, et al.
Publicado: (2021)

Apolipoprotein E4 Exaggerates Diabetic Dyslipidemia and Atherosclerosis in Mice Lacking the LDL Receptor
por: Johnson, Lance A., et al.
Publicado: (2011)

Hematopoietic upstream stimulating factor 1 deficiency is associated with increased atherosclerosis susceptibility in LDL receptor knockout mice
por: Hoekstra, Menno, et al.
Publicado: (2021)

Pharmacological activation of lysophosphatidic acid receptors regulates erythropoiesis
por: Lin, Kuan-Hung, et al.
Publicado: (2016)

Integrated Human Evaluation of the Lysophosphatidic Acid Pathway as a Novel Therapeutic Target in Atherosclerosis
por: Aldi, Silvia, et al.
Publicado: (2018)

Single-cell profiling reveals age-associated immunity in atherosclerosis
por: Smit, Virginia, et al.
Publicado: (2023)

Myeloid Deletion of α1AMPK Exacerbates Atherosclerosis in LDL Receptor Knockout (LDLRKO) Mice
por: Cao, Qiang, et al.
Publicado: (2016)

The Effect of Low-Dose Proteasome Inhibition on Pre-Existing Atherosclerosis in LDL Receptor-Deficient Mice
por: Wilck, Nicola, et al.
Publicado: (2017)

Membrane type 1 matrix metalloproteinase promotes LDL receptor shedding and accelerates the development of atherosclerosis
por: Alabi, Adekunle, et al.
Publicado: (2021)

Ethereal Extract of Pepper: Preventing Atherosclerosis and Left Ventricle Remodeling in LDL Receptor Knockout Mice
por: dos Santos, Leandro, et al.
Publicado: (2021)

Chemokines and their receptors in Atherosclerosis
por: van der Vorst, Emiel P. C., et al.
Publicado: (2015)

Effect of lysophosphatidic acid on the follicular development and the expression of lysophosphatidic acid receptor genes during in vitro culture of mouse ovary
por: Abedpour, Neda, et al.
Publicado: (2018)

Expression of lysophosphatidic acid receptors in the human lower esophageal sphincter
por: FENG, YONG, et al.
Publicado: (2014)

Abrogation of lysophosphatidic acid receptor 1 ameliorates murine vasculitis
por: Miyabe, Chie, et al.
Publicado: (2019)

Lysophosphatidic Acid Receptors: Biochemical and Clinical Implications in Different Diseases
por: Xiang, Hongjiao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tflmgpnjdnq31oc93r0aft2c5k